Detail

Keywords

Clinical Trials as Topic; Hypercholesterolemia; Lipid Metabolism Disorders; Metabolomics; Obesity; Pediatric Obesity; Pediatrics

Research interests

Dr. Julia Lischka, PhD, started her career in research focusing on childhood obesity in 2017 at the Department of Pediatrics, Medical University of Vienna, in the laboratory of the “Research Core Unit for Inflammation & Metabolism”.

During her time at the Medical University of Vienna, her reseach focused on metabolic and epigenetic markers associated with inflammation and obesity-associated metabolic comorbidities. Additionally, she is specialised in lipid metabolism disorders, particularly familial hypercholesterolemia.

Currently, her main research interest focuses on childhood obesity, particularly advancing obesity management and advancing novel treatments.

Grants

• FHCARE Familial Hypercholesterolemia: Children At Risk – Experimental markers (2022)
  Source of Funding: City of Vienna, Bürgermeisterfonds der Stadt Wien
  Principal Investigator
• FHCARE Familial Hypercholesterolemia: Children At Risk – Experimental markers (2021)
  Source of Funding: Medical University of Vienna, CCP Starter Grant
  Principal Investigator

Selected publications

1. Lischka, J. et al. (2022) ‘Tryptophan Metabolism Is Associated with BMI and Adipose Tissue Mass and Linked to Metabolic Disease in Pediatric Obesity’, Nutrients, 14(2), p. 286. Available at: http://dx.doi.org/10.3390/nu14020286.
2. Lischka, J. et al. (2021) ‘Circulating microRNAs 34a, 122, and 192 are linked to obesity-associated inflammation and metabolic disease in pediatric patients’, International Journal of Obesity, 45(8), pp. 1763–1772. Available at: http://dx.doi.org/10.1038/s41366-021-00842-1.
3. Lischka, J. et al. (2020) ‘A branched‐chain amino acid‐based metabolic score can predict liver fat in children and adolescents with severe obesity’, Pediatric Obesity, 16(4). Available at: http://dx.doi.org/10.1111/ijpo.12739.
4. Lischka:, J. et al. (2023) ‘Macrophage-associated markers of metaflammation are linked to metabolic dysfunction in pediatric obesity’, Cytokine, 171, p. 156372. Available at: https://doi.org/10.1016/j.cyto.2023.156372.
5. Lischka, J. et al. (2022) ‘Vascular access for lipid apheresis: a challenge in young children with homozygous familial hypercholesterolemia’, BMC Pediatrics, 22(1). Available at: http://dx.doi.org/10.1186/s12887-022-03192-7.